What is it?
The lipid management program at Loyola is designed to assist referring physicians with caring for patients who have difficult-to-treat lipid disorders, as well as those with a high risk for cardiac events. This is done through collaborating with the patient's cardiologist or primary care physician to complete advanced diagnostic testing, including plasmapheresis, and risk factor analysis.
Our goal is to prevent and slow down the mechanism by which lipids harden the walls of the arteries and cause plaque build-up (atherosclerosis), whether or not an individual shows symptoms. For patients with diagnosed heart conditions, near relatives may be screened, assessed, and proactively managed if they are found to have lipoprotein disorder. Patients with high cholesterol and other lipid and lipoprotein disorders, as well as those with a high risk, may be treated using dietary and pharmacologic therapies, along with lifestyle changes.
The Loyola difference
Loyola offers a team of cardiologists who are also board-certified by the American Board of Clinical Lipidology, providing them with unique expertise in advanced cholesterol and lipid management. In addition, we are one of few centers in the Chicago area to offer plasmapheresis for complex analysis of blood to define cardiac risk.
Loyola is a nationally recognized leader in cardiac care. U.S. News & World Report ranked us 18th in the nation for cardiology and heart surgery in 2012, making this our 10th year in the top 50.
Learn more about our performance outcomes.